PR Newswire

Long serving industry leader appointed to lead UK & Ireland data centre and critical power strategy, strengthening resilience, sustainability and…

New AI Agent Automation eliminates manual reporting, automates complex interoperability tasks, and enables system integration when APIs or technical expertise…

Transition marks next phase of Sign In Solutions’ evolution, uniting security, governance, and seamless experiences under new leadership ST. PETERSBURG,…

Quickplay’s AI achievements surpass industry hype, transforming emerging trends intoundeniable reality including 100%+ watch time increases, 130%+ ad fill rate…

AUSTIN, Texas, Jan. 6, 2026 /PRNewswire/ — Westlake Securities (“Westlake”), a leading Texas-based middle-market investment bank, today announced that it served…

SPRINGFIELD, Va., Jan. 6, 2026 /PRNewswire/ — Boosalis Properties announces the lease of 95,598 square feet at 7201 Wimsatt Road…

BOSTON, Jan. 6, 2026 /PRNewswire/ — Bambusa Therapeutics, Inc., a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology &…

Foundation funds five new research projects, bringing 2025 total to $5.2 million NEW YORK, Jan. 6, 2026 /PRNewswire/ — The…

EchoXBorder marks the latest addition to Echo’s growing cross-border operations  CHICAGO, Jan. 6, 2026 /PRNewswire/ — Echo Global Logistics, Inc.…

Legendary Texas AEC leader selects unified solutions to drive growth and efficiency DULLES, Va., Jan. 6, 2026 /PRNewswire/ — Unanet,…

Outlook highlights risks and opportunities investors face amid period of high tariffs, shrinking labor force and the continued U.S. debt…

Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid Leukemia Acquisition…

Blixeprodil, a novel, oral NMDA receptor antagonist, demonstrated rapid, robust, and durable antidepressant effects in Major Depressive Disorder Rapid and…

World’s Largest Lottery Games Company to Bring Players from Across U.S. to Exclusive Winners’ Event in Los Angeles Offering up…

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a…